DHR vs V: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Visa Inc. · Financial Services
$327.24
+27.8% upside to fair value
Grade A
High Quality
QuantHub Verdict
V has more upside to fair value
(+27.8%).
V trades at a lower forward P/E
(28.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
V |
| Current Price |
$195.98 |
$327.24 |
| Fair Value Estimate |
$211.54 |
$418.15 |
| Upside to Fair Value |
+7.9%
|
+27.8%
|
| Market Cap |
$138.7B |
$627.3B |
| Forward P/E |
37.8x
|
28.2x
|
| EV / EBITDA |
22.8x
|
22.6x
|
| Price / Sales |
5.6x
|
14.6x
|
| Price / FCF |
26.2x
|
29.6x
|
| Revenue Growth YoY |
+3.7%
|
+17.1%
|
| Gross Margin |
60.7%
|
81.3%
|
| Operating Margin |
21.0%
|
61.1%
|
| Return on Equity |
7.1%
|
58.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
3.38%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Visa Inc. operates a global payments network that facilitates electronic funds transfers worldwide, primarily through credit and debit cards. The company benefits from a very strong and widening moat driven by its extensive global card network and acceptance infrastructure, supported by a shareholder-friendly capital allocation policy including high buybacks and dividends. Visa's business quality…
Accumulation Zones
| Metric |
DHR |
V |
| Zone Low |
$158.66 |
$313.61 |
| Zone High |
$179.81 |
$355.43 |
| In Buy Zone? |
No
|
Yes
|